Investment House LLC reduced its stake in shares of Monsanto Co. (NYSE:MON) by 3.0% during the second quarter, Holdings Channel reports. The institutional investor owned 11,020 shares of the company’s stock after selling 340 shares during the period. Investment House LLC’s holdings in Monsanto were worth $1,140,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of MON. Howard Hughes Medical Institute acquired a new stake in shares of Monsanto during the first quarter valued at about $110,000. Carnick & Kubik LLC purchased a new stake in Monsanto during the first quarter worth $130,000. Palladium Partners LLC purchased a new stake in Monsanto during the second quarter worth $205,000. First Quadrant L P CA increased its stake in Monsanto by 42.9% in the second quarter. First Quadrant L P CA now owns 2,000 shares of the company’s stock worth $207,000 after buying an additional 600 shares during the period. Finally, Albion Financial Group UT purchased a new stake in Monsanto during the second quarter worth $210,000. 79.06% of the stock is currently owned by institutional investors.

Shares of Monsanto Co. (NYSE:MON) traded up 1.44% during trading on Wednesday, hitting $104.36. 5,719,552 shares of the stock traded hands. The firm has a 50-day moving average of $105.82 and a 200-day moving average of $100.43. Monsanto Co. has a 1-year low of $81.22 and a 1-year high of $114.26. The firm has a market capitalization of $45.67 billion, a price-to-earnings ratio of 45.93 and a beta of 1.24.

Monsanto (NYSE:MON) last issued its quarterly earnings data on Wednesday, June 29th. The company reported $2.17 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $2.40 by $0.23. The company earned $4.19 billion during the quarter, compared to the consensus estimate of $4.49 billion. Monsanto had a net margin of 7.76% and a return on equity of 37.98%. Monsanto’s revenue for the quarter was down 8.5% on a year-over-year basis. During the same period in the previous year, the company earned $2.39 EPS. On average, equities analysts forecast that Monsanto Co. will post $4.46 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, October 7th will be paid a $0.54 dividend. This represents a $2.16 annualized dividend and a yield of 2.07%. The ex-dividend date of this dividend is Wednesday, October 5th. Monsanto’s payout ratio is 89.26%.

A number of equities research analysts recently weighed in on the company. Sanford C. Bernstein reissued a “sell” rating on shares of Monsanto in a research report on Sunday, May 29th. Jefferies Group reissued a “buy” rating on shares of Monsanto in a research report on Wednesday, June 29th. Piper Jaffray Cos. set a $128.00 target price on Monsanto and gave the stock a “buy” rating in a research report on Thursday, September 15th. Citigroup Inc. reissued a “neutral” rating and set a $112.00 target price (up from $94.00) on shares of Monsanto in a research report on Friday, July 1st. Finally, Zacks Investment Research raised Monsanto from a “sell” rating to a “hold” rating in a research report on Wednesday, June 8th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company. Monsanto has an average rating of “Hold” and a consensus target price of $113.02.

In related news, COO Brett D. Begemann sold 27,980 shares of the stock in a transaction that occurred on Thursday, July 14th. The shares were sold at an average price of $103.62, for a total value of $2,899,287.60. Following the completion of the transaction, the chief operating officer now owns 102,480 shares of the company’s stock, valued at approximately $10,618,977.60. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Michael K. Stern sold 12,797 shares of the stock in a transaction that occurred on Wednesday, July 13th. The shares were sold at an average price of $101.77, for a total transaction of $1,302,350.69. Following the completion of the transaction, the chief executive officer now directly owns 21,583 shares of the company’s stock, valued at approximately $2,196,501.91. The disclosure for this sale can be found here. 0.88% of the stock is currently owned by corporate insiders.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

5 Day Chart for NYSE:MON

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Co. (NYSE:MON).

Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.